| 发明名称 |
Oral sustained-release tablet |
| 摘要 |
(Object) An oral sustained-release tablet is provided, which does not cause initial rapid increases in the bloodlevels of 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide (KRP-197) and can maintain constant the blood levels. (Solving means) An oral sustained-release tablet comprises a pharmaceutical composition and a gel-forming material, the pharmaceutical composition containing KRP-197 as an active ingredient.
|
| 申请公布号 |
US8343544(B2) |
申请公布日期 |
2013.01.01 |
| 申请号 |
US20100855226 |
申请日期 |
2010.08.12 |
| 申请人 |
KYORIN PHARMACEUTICAL CO., LTD.;ONO PHARMACEUTICAL CO., LTD.;HOSHINO RYOUICHI;NAKASHIMA KATASHI;KAZAMA KAZUO |
发明人 |
HOSHINO RYOUICHI;NAKASHIMA KATASHI;KAZAMA KAZUO |
| 分类号 |
A61K9/22;A61K9/20;A61K31/4174;A61K47/38;A61P13/00;A61P43/00;C07D233/61 |
主分类号 |
A61K9/22 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
